PRELUDE CAPITAL MANAGEMENT, LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2020$56,000
-24.3%
2,0170.0%0.00%
-25.0%
Q2 2020$74,0002,017
+50325.0%
0.00%
Q1 2020$0
-100.0%
4
-99.7%
0.00%
-100.0%
Q4 2019$60,000
+566.7%
1,466
+870.9%
0.00%
+100.0%
Q1 2019$9,000
-40.0%
151
-24.5%
0.00%0.0%
Q3 2018$15,000
-97.8%
200
-97.9%
0.00%
-97.6%
Q2 2018$669,000
+167.6%
9,325
+11.5%
0.04%
+133.3%
Q1 2018$250,000
+25.0%
8,360
+38.1%
0.02%0.0%
Q3 2017$200,000
+80.2%
6,055
+7.4%
0.02%
+63.6%
Q2 2017$111,000
+146.7%
5,639
+141.9%
0.01%
+175.0%
Q1 2017$45,0002,3310.00%
Other shareholders
REGENXBIO INC shareholders Q1 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 1,459,128$110,164,0006.60%
ArchPoint Investors 224,187$16,926,0004.60%
Redmile Group, LLC 1,656,065$125,033,0003.85%
WS MANAGEMENT LLLP 954,812$72,088,0002.37%
HIGHLINE CAPITAL MANAGEMENT, L.P. 342,000$25,821,0001.19%
Perceptive Advisors 470,672$35,536,0000.95%
Pier Capital, LLC 94,492$7,134,0000.90%
Ipswich Investment Management Co., Inc. 29,932$2,260,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,000$20,763,0000.74%
Timpani Capital Management LLC 27,835$2,102,0000.61%
View complete list of REGENXBIO INC shareholders